Testosterone Enanthate Cost in Nevada 2026

What Does Testosterone Enanthate Actually Cost in Nevada?

The average cash-pay price for testosterone enanthate at Nevada retail pharmacies in 2026 runs approximately $70 per month for a standard 200 mg/mL, 10 mL vial. The manufacturer list price sits closer to $120 per month. Those two numbers diverge because generic competition has pushed retail pricing down significantly since branded Delatestryl lost patent protection.

Retail Pharmacy Price Range

Prices vary by pharmacy chain and by the specific vial size dispensed. A single-dose 1 mL vial (200 mg/mL) at a Las Vegas Walgreens or a Reno CVS typically runs $25 to $35 per vial before any discount card. A 10 mL multi-dose vial, which supplies roughly 10 weekly injections at 1 mL per week, commonly prices out at $65 to $85 cash-pay. Calling ahead matters, since the same generic can differ by $20 or more across ZIP codes within Clark County alone.

The FDA-approved labeling for testosterone enanthate injection covers concentrations of 200 mg/mL and standard vial sizes used in these retail formulations. [1]

Compounded Testosterone Enanthate: ~$80 per Month

Nevada-licensed 503A compounding pharmacies can legally prepare testosterone enanthate for individual patients when a licensed prescriber writes a patient-specific prescription. The average price for compounded testosterone enanthate in Nevada runs about $80 per month, which is modestly above the retail generic cash-pay price. Compounding is not cheaper by default.

Why would a patient choose compounding at a higher price? Some prescribers use compounding to prepare specific concentrations (such as 100 mg/mL for easier dose titration), add a different carrier oil, or create smaller injection volumes for patients who tolerate standard sesame oil poorly. The FDA distinguishes 503A patient-specific compounding pharmacies from 503B outsourcing facilities; both types operate in Nevada. [2]

Telehealth Pricing Adds a Layer

Nevada permits telehealth prescribing of Schedule III controlled substances, including testosterone enanthate, under the Ryan Haight Online Pharmacy Consumer Protection Act framework and Nevada Revised Statutes chapter 639. A telehealth TRT clinic typically charges a monthly membership or consultation fee of $75 to $150 on top of the pharmacy dispensing cost. The total out-of-pocket through a telehealth provider may therefore run $145 to $220 per month when medication and platform fees are combined.

Does Nevada Medicaid Cover Testosterone Enanthate?

Nevada Medicaid does not cover testosterone enanthate for male hypogonadism. This is a firm policy position, not a prior-authorization hurdle that can be cleared with documentation of low serum testosterone alone.

Why Medicaid Excludes It

Nevada Medicaid's preferred drug list (PDL) excludes testosterone products for male hypogonadism as a non-covered benefit category. The exclusion reflects a federal and state-level determination that testosterone replacement therapy for hypogonadism falls into a category of lifestyle or non-urgent medications for purposes of Medicaid reimbursement. A prescriber cannot override this with a prior-authorization request under current Nevada Health and Human Services policy.

This stands in contrast to certain other states where Medicaid covers testosterone products for specific diagnoses (Klinefelter syndrome, surgical castration, or gender-affirming hormone therapy). Nevada's coverage rules differ by indication, so patients should verify their specific diagnosis code with a Nevada DHHS representative before assuming coverage.

What About Medicaid for Female Patients?

Nevada Medicaid coverage for testosterone in female patients (for conditions such as female hypoactive sexual desire disorder or gender-affirming hormone therapy) follows a separate prior-authorization pathway and is not automatically excluded in the same way. Female patients should request a formulary exception review.

Nevada Medicaid Alternative: Medicare Part D

For patients 65 and older or those with qualifying disabilities, Medicare Part D plans sold in Nevada may cover testosterone enanthate. Coverage depends on the specific plan formulary. In 2026, most Part D plans that include testosterone enanthate place it on Tier 2 or Tier 3, with a typical copay of $10 to $45 per month during the initial coverage phase.

The T-Trials (Testosterone Trials), published in the New England Journal of Medicine in 2016 (N = 790 men aged 65 or older), demonstrated improvements in sexual function, physical function, and bone mineral density with testosterone treatment, providing a clinical evidence base that informs Medicare coverage decisions. [3] Patients using Medicare should ask their Part D plan specifically whether testosterone enanthate injection or testosterone cypionate injection is preferred, since plans differ in which injectable they place on lower tiers.

Which Private Insurance Plans Cover Testosterone Enanthate in Nevada?

Most major commercial insurance carriers operating in Nevada, including Anthem Blue Cross Blue Shield Nevada, UnitedHealthcare, Aetna, and Cigna, list testosterone enanthate on their formularies as a covered benefit for diagnosed hypogonadism (ICD-10 code E29.1). Coverage is not automatic; a prior authorization (PA) requiring documented low serum testosterone (typically two morning total testosterone values below 300 ng/dL) and relevant symptoms is standard practice.

Prior Authorization Requirements

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism states: "We suggest making the diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone concentrations." [4] Insurers use this guideline threshold when evaluating PA requests.

A typical Nevada commercial PA packet for testosterone enanthate requires:

• Two fasting morning total testosterone levels below 300 ng/dL, drawn at least one week apart
• Documentation of symptoms (decreased libido, fatigue, reduced muscle mass)
• Confirmation that secondary causes (pituitary adenoma, sleep apnea) have been evaluated
• Prescriber attestation that the patient has a confirmed diagnosis of hypogonadism

Anthem Blue Cross Blue Shield Nevada's 2026 formulary places generic testosterone enanthate on Tier 2 with a 30-day copay of approximately $15 to $40 for most commercial plans. UnitedHealthcare plans in Clark County and Washoe County generally match that tier placement.

After Prior Authorization Is Approved

Once approved, the monthly cost with commercial insurance typically drops to $10 to $50 depending on the patient's deductible status, copay tier, and whether a generic or brand product is dispensed. Patients on high-deductible health plans will pay closer to retail price until the deductible is met.

Compounded Testosterone Enanthate: Nevada Legality and Regulation

Compounded testosterone enanthate is legal in Nevada when prepared by a pharmacy holding a current Nevada State Board of Pharmacy 503A license and dispensed pursuant to a patient-specific prescription from a Nevada-licensed prescriber. [5]

503A vs. 503B Distinctions

Under the federal Drug Quality and Security Act, 503A pharmacies compound for individual patients on a prescription-by-prescription basis. They may not produce large batches for office stock. Nevada pharmacies operating under a 503A designation can compound testosterone enanthate in concentrations and carrier oils not available in commercial generics.

503B outsourcing facilities operate under stricter FDA oversight and can produce larger quantities, but they typically supply medical practices rather than dispensing directly to individual patients. Nevada does have registered 503B facilities, though testosterone enanthate compounding from 503B facilities is subject to FDA bulk drug substance lists. [2]

Is Compounded Testosterone Enanthate as Effective?

The active pharmaceutical ingredient in compounded testosterone enanthate is chemically identical to the FDA-approved generic. No published randomized trial has compared compounded versus commercial testosterone enanthate head-to-head on pharmacokinetic outcomes in a large sample. Potency and sterility, however, depend on pharmacy quality controls, which is why the Nevada State Board of Pharmacy conducts regular inspections of 503A compounders. [5]

How to Get the Cheapest Testosterone Enanthate in Nevada

The cheapest path for most uninsured Nevada patients combines a GoodRx or similar discount card with a generic 10 mL vial at a high-volume retail pharmacy in Las Vegas or Reno.

Discount Cards and Coupon Programs

GoodRx prices for generic testosterone enanthate 200 mg/mL, 10 mL vial in Las Vegas ZIP codes (89101, 89119) have ranged from $38 to $62 in early 2025, depending on pharmacy. These prices are lower than the $70 average retail cash-pay precisely because discount cards negotiate pre-established rates with pharmacy benefit managers.

Manufacturer savings programs: Pfizer (manufacturer of Depo-Testosterone, a cypionate formulation) and West-Ward/Hikma (a manufacturer of generic testosterone enanthate) do not currently offer broad consumer-facing savings cards equivalent to GLP-1 manufacturer programs. Patient assistance programs (PAPs) exist for some testosterone products for patients below 200% of the federal poverty level; eligibility requires documentation of income and lack of insurance coverage. [6]

Mark Cuban's Cost Plus Drugs

Cost Plus Drugs (costplusdrugs.com) listed testosterone enanthate 200 mg/mL among its catalog in 2024 at prices in the range of $12 to $22 per vial at the manufacturer cost-plus-15% model. Nevada residents can use Cost Plus Drugs if their prescriber sends a prescription to that pharmacy and they pay out-of-pocket, though not all prescribers are familiar with the platform.

Splitting Vials

A 10 mL multi-dose vial at $65 to $85 cash-pay provides 10 weekly 1 mL injections at 200 mg each, reducing the effective per-injection cost to $6.50 to $8.50 if the full vial is used before expiration. Multi-dose vials should be used within 28 days of first puncture per standard pharmacy guidelines to reduce contamination risk. [1]

Telehealth TRT Prescribing in Nevada: What Patients Should Know

Nevada law permits telemedicine prescribing of Schedule III controlled substances when specific conditions are met. The prescriber must hold a valid Nevada medical license, conduct a synchronous audio-visual consultation, and establish a legitimate patient-physician relationship before issuing a controlled substance prescription. [7]

What a Telehealth TRT Visit Requires

A compliant Nevada telehealth TRT evaluation includes:

• A live video visit (audio-only is not sufficient for Schedule III prescribing)
• Review of lab work (morning total testosterone, LH, FSH, hematocrit, PSA in men over 40)
• Medical history and physical examination documentation
• A valid Nevada-licensed prescriber signing the prescription

The Endocrine Society guideline recommends checking hematocrit before initiating testosterone therapy and at 3 to 6 months, then annually, because testosterone stimulates erythropoiesis and can raise hematocrit above 54%, increasing thrombosis risk. [4] Telehealth platforms operating in Nevada must meet this standard; patients should confirm the platform arranges lab draws through a local Quest Diagnostics or LabCorp before prescribing.

HealthRX Telehealth Pricing in Nevada

HealthRX serves Nevada patients through its licensed telehealth platform. As of January 2026, HealthRX's Nevada testosterone enanthate program includes initial lab work coordination, a licensed physician video visit, prescription transmission to the patient's preferred Nevada pharmacy, and monthly follow-up messaging for a monthly membership fee. Patients pay pharmacy costs separately; HealthRX does not mark up medication prices.

Monitoring Costs: Labs and Follow-Up

The medication itself is only part of the monthly cost picture. Responsible testosterone therapy requires periodic laboratory monitoring. Expect these additional costs for uninsured Nevada patients:

A baseline lab panel (total testosterone, free testosterone, LH, FSH, PSA, CBC, comprehensive metabolic panel) at a self-pay LabCorp or Quest location in Nevada runs approximately $85 to $150 depending on which tests are ordered and whether a discount lab service such as Ulta Lab Tests is used.

Follow-up labs at 3 months post-initiation (hematocrit, total testosterone, PSA) run $40 to $70 cash-pay. The Endocrine Society guideline specifies testosterone monitoring at 3 and 6 months in the first year, then annually if stable. [4]

A 2016 analysis published in JAMA Internal Medicine found that monitoring costs and prescribing patterns for testosterone varied significantly by provider type, underscoring that choosing a protocol-driven telehealth provider can reduce unnecessary repeat testing. [8]

Clinical Evidence Supporting Testosterone Enanthate Use

Testosterone enanthate is not a lifestyle supplement. It is an FDA-approved Schedule III medication with a defined evidence base for male hypogonadism.

The T-Trials

The Testosterone Trials (T-Trials) enrolled 790 men aged 65 and older with low testosterone (below 275 ng/dL) across seven coordinated double-blind placebo-controlled trials. Published in the New England Journal of Medicine in 2016, the primary sexual function trial showed a mean improvement of 1.2 points on the PDAS-II scale for sexual activity (P<0.001) with testosterone gel compared to placebo. [3] The trials used transdermal testosterone but the pharmacodynamic findings apply across delivery routes that achieve equivalent serum levels.

Bone Mineral Density Data

The T-Trials bone trial showed a 0.9% increase in volumetric bone mineral density of the spine in the testosterone group versus a 1.3% decrease in the placebo group at 12 months (P<0.001). [9] This datum is relevant for Nevada patients considering testosterone therapy as part of osteoporosis management in hypogonadal men.

Cardiovascular Considerations

The FDA requires a boxed warning on all testosterone products regarding venous thromboembolism. The TRAVERSE trial (N = 5,246, published 2023) found that testosterone replacement did not increase major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months in men with hypogonadism and elevated cardiovascular risk. [10] This is reassuring but does not eliminate the need for individualized cardiovascular risk assessment before initiating therapy.

Practical Checklist Before Starting Testosterone Enanthate in Nevada

Before a Nevada prescriber writes a testosterone enanthate prescription, the standard of care includes the following steps, each relevant to both clinical safety and insurance approval:

1. Confirm two fasting morning total testosterone values below 300 ng/dL, drawn at least one week apart. [4]
2. Rule out secondary causes: obtain LH, FSH, and prolactin levels. Elevated prolactin warrants pituitary MRI before starting testosterone.
3. Obtain baseline hematocrit, PSA (men over 40), and a lipid panel.
4. Document symptoms using a validated tool such as the Aging Males' Symptoms (AMS) scale.
5. Review contraindications: prostate cancer, breast cancer, untreated severe sleep apnea, hematocrit above 50%.
6. Select injection technique: intramuscular (gluteal, vastus lateralis, or deltoid) versus subcutaneous, depending on patient anatomy and preference. [1]
7. Arrange follow-up labs at 6 to 8 weeks post-initiation to confirm testosterone trough levels are in the mid-normal range (400 to 700 ng/dL).

For most patients on once-weekly 100 to 200 mg intramuscular testosterone enanthate, trough levels measured just before the next injection should fall between 400 and 700 ng/dL per Endocrine Society targets. [4]